Atara Biotherapeutics (ATRA) EBITDA Margin (QoQ) (2021 - 2026)
Atara Biotherapeutics (ATRA) EBITDA Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | Atara Biotherapeutics | 139.81 Mn | 123.25 Mn | 439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9,630.00 |
| Mar 31, 2026 | -49,222.00 |
| Dec 31, 2025 | -5,719.00 |
| Sep 30, 2025 | -12,169.00 |
| Jun 30, 2025 | -2,134.00 |
| Mar 31, 2025 | 7,679.00 |
| Dec 31, 2024 | 1,688.00 |
| Sep 30, 2024 | 952.00 |
| Jun 30, 2024 | 5,056.00 |
| Mar 31, 2024 | -210,631.00 |
| Dec 31, 2023 | 543,823.00 |
| Sep 30, 2023 | 4.01 Mn |
| Jun 30, 2023 | -3.51 Mn |
| Mar 31, 2023 | -422,568.00 |
| Dec 31, 2022 | -236,274.00 |
| Sep 30, 2022 | -183,548.00 |
| Dec 31, 2021 | 34,191.00 |
| Sep 30, 2021 | 59,123.00 |
| Jun 30, 2021 | 3,225.00 |